The COPACC Study: Utilization, Health and Economic Evaluation of a Community-Based Primary Care Geriatric Hub at Whampoa

Quality of Life Clinical Trial

Official title:

The Community for Successful Ageing (ComSA) Patient-Centered Care (COPACC) Study: Utilization, Health and Economic Evaluation of a Community-Based Primary Care Geriatric Hub at Whampoa, Singapore.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04594967
• Other study ID #: 2017/00352
• Status: Completed
• Start date: October 4, 2017
• Est. completion date: June 30, 2020

Study information

• Verified date: October 2020
• Source: Geriatric Education and Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the Community for Successful Ageing (ComSA) Patient-Centered Medical Home (PCMH), a model of community-based primary care geriatric hub at Whampoa, Singapore.

Description:

This study evaluates the Community for Successful Ageing (ComSA) Patient-Centered Medical Home (PCMH), a model of community-based primary care geriatric hub at Whampoa, Singapore. This study aims to evaluate the impact of ComSA PCMH on health service utilisation, healthcare cost, clinical quality and effectiveness, as well as patient activation, quality of life, satisfaction and experience of care. The first component of the study is a single arm prospective pre-post cohort design, which aims to evaluate the impact on enrolled patients' self-reported health outcomes, experience of care, and cost effectiveness. The second component of the study evaluates the quality of the implementation processes via clinical quality indicators. The third component is a match-controlled retrospective pre-post study design, which aims to evaluate the impact on healthcare utilisation. Data sources include both survey data and administrative data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 184
• Est. completion date: June 30, 2020
• Est. primary completion date: April 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 99 Years

Eligibility

Key inclusion criteria:

i. Aged 40 years and above ii. Lives in Whampoa, Singapore iii. Enrolled in PCMH after 1 September 2017 Exclusion criteria: i. Aged less than 40 years ii. Does not live in Whampoa Singapore

Related Conditions & MeSH terms

• Costs and Cost Analysis
• Delivery of Health Care
• Health Services
• Quality of Life

Intervention

Other:
• Patient-centred care home (PCMH)
New model of care defined by care provision by a team of people centered in the community that is both proactive and coordinated to improve the health and wellness of the people in that community.

Locations

Country	Name	City	State
Singapore	Geriatric Education and Research Institute	Singapore

Sponsors (3)

Lead Sponsor	Collaborator
Geriatric Education and Research Institute	National Healthcare Group, Singapore, Tsao Foundation

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healthcare utilisation: Primary care	Primary care visits	Change from baseline to post-3 months, and to post-6 months
Primary	Healthcare utilisation: Inpatient visits	Inpatient visits	Change from baseline to post-3 months, and to post-6 months
Primary	Healthcare utilisation: Specialist outpatient care	Specialist outpatient clinic visits	Change from baseline to post-3 months, and to post-6 months
Primary	Healthcare utilisation: A&E	A&E visits	Change from baseline to post-3 months, and to post-6 months
Primary	Patient-reported outcome measure for patient activation	PAM-13	Change from baseline to post-3 months, and to post-6 months
Primary	Patient-reported outcome measure for quality of life	EQ-5D-5L	Change from baseline to post-3 months, and to post-6 months
Primary	Patient-reported outcome measure for quality of life in old age	CASP-19	Change from baseline to post-3 months, and to post-6 months
Primary	Patient experience of care	CAHPS	6 months
Primary	Economic evaluation and cost analysis	Cost comparison between intervention group and non-intervention group	Change from baseline to post-3 months, and to post-6 months